Investigational Site Number :3800001

Rozzano, Milano 20089

1 studies enrolling now · 4 studies all time

What they study most

Neurodermatitis, Non-small Cell Lung Cancer, Plasma Cell Myeloma, Plasma Cell Myeloma Refractory, Pleural Mesothelioma

Studies at this site

• A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma — Recruiting now
• Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) — Stopped early
• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) — Completed